Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids
โ Scribed by L. M. Larocca; M. Piantelli; G. Leone; S. Sica; L. Teofili; P. Benedetti Panici; G. Scambia; S. Mancuso; A. Capelli; F. O. Ranelletti
- Book ID
- 114712180
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 621 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Type4 estrogen-binding sites (type-ll EBS) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-'H) estradiol ('H-E,) as tracer. Competition analysis showed that the anti-estrogen tamoxifen and the flavonoids quercetin and rutin competed for (lH)-E, bi
Quercetin and tamoxifen, in a range of concentrations between 0.01 and 5 M, exert a dose-dependent inhibition on the anchorage-dependent and anchorage-independent cell growth of Hep2 and CO-K3 laryngeal cancer cell lines. Cell cycle analysis revealed that the growth-inhibitory effect was associated